Research
Hormonal
At 12 months, total weight loss was higher in the treatment group (35.77% ± 8.35%) compared to controls (28.37% ± 7.41%; p < 0.0001).
The findings support the use of semaglutide for improved long-term weight management post-surgery.
StrongSupportsmedium confidence
At 12 months, TWL was also higher in the treatment group (35.77% ± 8.35% vs. 28.37% ± 7.41%; p < 0.0001).
Why this rating
The study design is a retrospective analysis with matched controls, indicating strong evidence.
Source
Short‐Term Weight Loss Outcomes of 1.0 <scp>mg</scp> Semaglutide Therapy Initiated 6 Months After Sleeve Gastrectomy
Min He et al. · Obesity · 2025
cohort · n=136Cited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →